Navigation Links
Thoma & Sutton Eye Care Launches ChromaGen Life-Changing Lens Technology
Date:4/3/2013

CINCINNATI, April 3, 2013 /PRNewswire/ -- Words that move from left to right or up and down, words that are blurry or come in and out of focus or words that appear to float on the page, seeing double words or double sentences, re-reading the same lines - these are some of the reading difficulties that students everywhere are struggling with.  These symptoms can cause headaches, nausea, and fatigue, loss of concentration and even avoidance of reading all together. Now there is hope with the new, patented and FDA cleared ChromaGen lenses. These lenses are a life changing aid for people with dyslexia and other reading disorders.

The ChromaGen lenses were developed by Dr. David Harris , who has concluded after years of studying dyslexia the majority of people who have dyslexia see words that appear to be moving on the page in some way.

"Approximately 90 percent of these people who see words moving will benefit from ChromaGen lenses," said Harris, who has a PhD in Neurological Implications and Assistance for Reading Disability from Marylebone University in London. "Individuals that use ChromaGen lenses will experience instantaneous symptom relief. The patient will see an immediate improvement in reading speed, comprehension and even an improvement in handwriting."

"We are excited to provide this much needed technology," said Lance Snarr , CEO of Thoma & Sutton Eye Care Centers .  "Dyslexia and reading problems can negatively impact the future success of any individual whether in a school setting or a work setting. The ChromaGen lenses are not a cure for dyslexia or reading problems; they are a symptomatic treatment option. The lenses can offer an increase in reading speed and comprehension and an improvement in handwriting. We look forward to sharing this innovative technology."

The ChromaGen technology is an optical treatment option that employs sixteen different filtered lenses. The lenses modify lights' wavelength as it passes into each eye, which dynamically balances the speed of the information traveling along the neurological pathways to the brain. The result is that people are now seeing words and text is clear and in focus.  They now enjoy reading free of headaches, nausea and fatigue.

Dr. Edward Huggett , D.O. and Chief Optometric Advisor for ChromaGen Vision, LLC says, "I am prescribing the ChromaGen technology because it provides relief for those patients who have experienced 'word movement' while reading for so long that they have lost hope. Now these chronic sufferers have options."

ChromaGen lenses are available through a nationwide network of specially trained optometrists or ophthalmologists. The results are instantaneous and the patients will know immediately before leaving the doctor's office if ChromaGen is an effective solution for them. ChromaGen lenses come with a 100 percent money back guarantee.

To schedule a screening call Thoma & Sutton Eye Care at toll free: (855)-843-8720. To locate your nearest Thoma & Sutton Eye Doctor visit: www.ThomaSuttonChromaGen.com

For media or news information, www.ChromaGenPressKit.com. or for more information about the ChromaGen lens technology, www.IReadBetterNow.com.

About ChromaGen
ChromaGen eyeglasses and contacts lenses are patented and have been cleared by the U.S. Food and Drug Administration (FDA).

About Thoma & Sutton Eye Care
Established in 1949, Thoma & Sutton has grown to 20 locations in Cincinnati, Dayton and Cleveland. They offer the very best in precision ground optical lenses, fashionable and luxury brand eyeglasses, state of the art contact lenses, and comprehensive eye-examinations by licensed and highly trained independent Doctors of Optometry.

Contact:
Jo Hunt
DHA Lifestyle PR
jo@delyon-hunt.com
o. 310.541.2800
c. 310.413.1157 


'/>"/>
SOURCE ChromaGen
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
2. Exclusive Industry Panel for Medical Device Developers - "The Great Innovators: A Sit-Down Chat with Dr. Thomas Fogarty & Dean Kamen"
3. SurgLine International, Inc. Chief Executive Officer, Thomas Toland, Exclusive Interview on Stock Traders Talk Radio
4. UBM Canon, the Global MedTech Authority, and the Medical Design Excellence Awards Honored Dr. Thomas Fogarty with the 2012 Lifetime Achievement Award
5. Aethlon Medical Announces the Appointment of Thomas V. Wornham and Philip A. Ward to its Board of Directors
6. PeriGen, Inc. Names American Journal of OBGYN Editor-In-Chief Thomas J. Garite MD, Chief Clinical Officer
7. Vermillion Appoints Thomas McLain as President and Chief Executive Officer
8. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
9. Smith & Nephew launches revolutionary open-architecture suture anchor for rotator cuff repair with greater pullout strength than competitors[i]
10. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
11. Biopharma M&A Trends Hold Steady, But Deals Declined in 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, ... at his family verbally and physically. , “When something upset him, he couldn’t control his ... it. He would throw rocks at my other children and say he was going to ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):